Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Fig. 3

Diversity of AR-positive triple-negative feline mammary carcinomas. Left panel, non-basal-like AR+ FOXA1+ CK14– triple-negative feline invasive mammary carcinomas determined by immunohistochemistry were characterized by: ER negativity (a), PR negativity (b), HER2 negativity (c), AR positivity (d), FOXA1 positivity (e), and CK14 negativity (f). Right panel, basal-like AR+ FOXA1– CK14+ triple-negative feline invasive mammary carcinomas determined by immunohistochemistry were characterized by: ER negativity (g), PR negativity (h), HER2 negativity (i), AR positivity (j), FOXA1 negativity (k), and CK14 positivity (l). Peroxidase-DAB revelation system. Original magnification 400x. Bar = 20 μm

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us